<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><link rel="stylesheet" type="text/css" href="style.css"/><link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css" integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm" crossorigin="anonymous" /><title></title></head><body><div class="container"><h1>OT05240:</h1><h2>Ineffective Nomination - How To Calculate Nomination Excesses</h2><hr /><div contenteditable="true" class="container" style="width: 50%; height: 50%; float:left;"><h3>Old version</h3><hr /><p></p><p>Where a company delivers equity oil arm&#8217;s length under a BFO contract and the sale under that contract has not been effectively nominated, the company needs to establish whether a nomination excess arises.</p><p>Such a delivery is called a &#8216;relevant delivery&#8217;.</p><h3>FA87\\S61(3)</h3><p>In order to establish whether a nomination excess arises in relation to a relevant delivery (and if so the quantum of the excess), the company must compare:</p><li><lilabel></lilabel><p>The proceeds of the relevant delivery, </p></li><p>with </p><li><lilabel></lilabel><p>The market value of that delivery ascertained in accordance OTA75\\Sch3 (see <remotelink dpsi="0Y02" refpt="0Y02_OT05305:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid">OT05305</remotelink> onwards).</p></li><p>Where B is greater than A a nomination excess arises. The quantum of the nomination excess is the difference between B and A.</p><table colsep="0" frame="none" pgwide="1" rowsep="0"><tgroup cols="2" colsep="0" rowsep="0"><colspec colname="C1" colnum="1" colsep="0" colwidth="50%" rowsep="0" /><colspec colname="C2" colnum="2" colsep="0" colwidth="50%" rowsep="0" /><tbody><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Example:</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">&#160;</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Relevant delivery proceeds: $52 x 600k bbls = $31,200,000</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Date of relevant delivery: 05 January.</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Market value in respect of that delivery: $53 x 600k bbls = $31,800,000</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">$31,800,000 - $31,200,000 = $600,000</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">So (assume exchange rate of 0.5) nomination excess = &#163;300,000.</td></tr></tbody></tgroup></table><h3>FA87\\S61(4)</h3><p>Where the relevant delivery is a delivery of blended oil, and the participator has at least one taxable field interest (see <remotelink dpsi="0Y02" refpt="0Y02_OT03100:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid">OT03100</remotelink>) in the blend, then Regulation 10 SI2006 No. 3312 (see <remotelink dpsi="0Y02" refpt="0Y02_OT05245:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid">OT05245</remotelink> below) will apply to determine the proportion of any excess to attribute to each of a company&#8217;s &#8216;new&#8217; field interests in the blend.</p><p>The total of a participator&#8217;s excesses in a month determines the monthly excesses for each month (FA87\\S61(4A)).</p><p>The excess nominated proceeds in a chargeable period for each oil field are the sum of that field&#8217;s share (determined under Regulation 10) of the monthly excesses for each month of the chargeable period (FA87\\S61(4B)). </p><p>These excess nominated proceeds are brought into the participator&#8217;s gross profits from the field for the chargeable period under OTA75\\S2(5(e) for the purposes of determining the participator&#8217;s PRT liability from that field for the chargeable period.</p><p>Please note: the participator&#8217;s monthly excesses from all it field interests in the blend will also be brought into charge for CT and SC(see <remotelink dpsi="0Y02" refpt="0Y02_OT05250:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid">OT05250</remotelink> below).</p><p></p><li><lilabel></lilabel><p><remotelink dpsi="0Y02" refpt="0Y02_OT05234:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Previous page </remotelink></p></li><li><lilabel></lilabel><p><remotelink dpsi="0Y02" refpt="0Y02_OT05245:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Next page </remotelink></p></li></div><div contenteditable="true" class="container" style="width: 50%; height: 50%; float:right;"><h3>New version</h3><hr /><p></p><p>Where a company delivers equity oil arm&#8217;s length under a BFO contract and the sale under that contract has not been effectively nominated, the company needs to establish whether a nomination excess arises.</p><p>Such a delivery is called a &#8216;relevant delivery&#8217;.</p><h3>FA87\\S61(3)</h3><p>In order to establish whether a nomination excess arises in relation to a relevant delivery (and if so the quantum of the excess), the company must compare:</p><li><lilabel></lilabel><p>The proceeds of the relevant delivery,</p></li><p>with</p><li><lilabel></lilabel><p>The market value of that delivery ascertained in accordance OTA75\\Sch3 (see OT05305 onwards).</p></li><p>Where B is greater than A a nomination excess arises. The quantum of the nomination excess is the difference between B and A.</p><table colsep="0" frame="none" pgwide="1" rowsep="0"><tgroup cols="2" colsep="0" rowsep="0"><colspec colname="C1" colnum="1" colsep="0" colwidth="50%" rowsep="0" /><colspec colname="C2" colnum="2" colsep="0" colwidth="50%" rowsep="0" /><tbody><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Example:</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">&#160;</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Relevant delivery proceeds: $52 x 600k bbls = $31,200,000</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Date of relevant delivery: 05 January.</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">Market value in respect of that delivery: $53 x 600k bbls = $31,800,000</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">$31,800,000 - $31,200,000 = $600,000</td></tr><tr rowsep="0"><td align="left" valign="top">&#160;</td><td align="left" valign="top">So (assume exchange rate of 0.5) nomination excess = &#163;300,000.</td></tr></tbody></tgroup></table><h3>FA87\\S61(4)</h3><p>Where the relevant delivery is a delivery of blended oil, and the participator has at least one taxable field interest (see <remotelink dpsi="0Y04" refpt="0Y04_OT03100:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid">OT03100</remotelink>) in the blend, then Regulation 10 SI2006 No. 3312 (see OT05245 below) will apply to determine the proportion of any excess to attribute to each of a company&#8217;s &#8216;new&#8217; field interests in the blend.</p><p>The total of a participator&#8217;s excesses in a month determines the monthly excesses for each month (FA87\\S61(4A)).</p><p>The excess nominated proceeds in a chargeable period for each oil field are the sum of that field&#8217;s share (determined under Regulation 10) of the monthly excesses for each month of the chargeable period (FA87\\S61(4B)).</p><p>These excess nominated proceeds are brought into the participator&#8217;s gross profits from the field for the chargeable period under OTA75\\S2(5(e) for the purposes of determining the participator&#8217;s PRT liability from that field for the chargeable period.</p><p>Please note: the participator&#8217;s monthly excesses from all it field interests in the blend will also be brought into charge for CT and SC(see OT05250 below).</p><p></p><li><lilabel></lilabel><p><remotelink dpsi="0Y04" refpt="0Y04_OT05234:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Previous page </remotelink></p></li><li><lilabel></lilabel><p><remotelink dpsi="0Y04" refpt="0Y04_OT05245:MANUAL-PARA" remotekey1="REFPTID" service="DOC-ID" status="valid"> Next page </remotelink></p></li></div></div></body></html>